Ledger.Open graph →

SEC Form D · filed November 16, 2022

Haystack Oncology, Inc

Offering

$67.0M

Sold

$67.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

George Petrocheilos · Bethesda, MDDirector Isaac Ro · BALTIMORE, MDDirector Olga Maltseva · BALTIMORE, MDExec R. Jacob Vogelstein · Bethesda, MDDirector Nickolas Papadopoulos · BALTIMORE, MDExec · Director Dan Edelstein · BALTIMORE, MDExec · Director George Petrocheilos · Bethesda, MDDirector R. Jacob Vogelstein · Bethesda, MDDirector Nickolas Papadopoulos · BALTIMORE, MDExec · Director Dan Edelstein · BALTIMORE, MDExec · Director Isaac Ro · BALTIMORE, MDDirector Olga Maltseva · BALTIMORE, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗